|
2006 Abstract Submission Page
Call for Abstracts
Meeting organizers invited the scientific community to
submit abstracts of their current research to be peer reviewed and considered
for inclusion in the scientific program. All accepted abstracts will be published
in the special meeting issue of Molecular
Imaging, the Society's award winning journal.
The online abstract submission system is now closed.
765 abstracts have been submitted, and the review process is underway. Abstract
submitters should know by June 8 the status of their submission.
The Scientific Program will be constructed in large part
from oral and poster abstract presentations reporting significant technological
advances relevant to imaging at the whole organism or cellular levels. Imaging
modalities may include nuclear medicine techniques (SPECT and PET) and non-nuclear
techniques such as MRI, MRS, CT, ultrasound, intravital microscopy, optical
imaging and diffuse optical tomography and other methods which elucidate molecular
and cellular mechanisms, accelerate understanding of biology, test efficacy
of therapeutic interventions in intact living systems and assess therapeutic
outcomes. Abstracts are limited to 300 words maximum (each table or graphic
counts as 25 words toward the 300-word maximum).
Abstracts should address one or more of the following
categories:
- Advances in MR Imaging
- Advances in Multimodality Imaging
- Advances in Optical Imaging
- Advances in PET/SPECT Imaging
- Bioinformatics
- Digital Imaging Processing
- Hyperpolarized Carbon-13 Molecular Imaging
- Imaging Biomarkers for Therapy (MR)
- Imaging Biomarkers for Therapy (PET)
- Imaging Cell Signaling Pathways
- Imaging Cell Surface Events
- Imaging in Autoimmune Diseases
- Imaging in Cardiovascular Disease
- Imaging in Neuroscience
- Imaging of Metabolic Diseases
- Immune Cell Imaging
- Oncologic Imaging
- Intravital Microscopic Imaging
- Molecular Imaging in the Drug Discovery Process
- Mouse Models of Human Diseases
- Nanotechnology
- New Imaging Probes (MR)
- New Imaging Probes (Optical)
- New Imaging Probes (PET/SPECT)
- New Imaging Probes (US)
- New Reporter Genes
- Stem Cell Imaging
- Temporal Imaging
- Imaging Other (i.e. EPR, thermal, etc)
Declaration of Financial Interests or Relationships
It is the policy of the Radiological Society for North America (RSNA) and the
Society for Molecular Imaging (SMI) that any speaker or poster presenter making
a presentation at a program designated for AMA Physician's Recognition Award
Category 1 credit must disclose any financial interest or other relationship
(i.e., grants, research support, consultant, honoraria, etc.) that the speaker
may have with the manufacturers, distributors or providers of any commercial
products or services that may be discussed in the presentation. Additionally,
corresponding authors must provide disclosure information for all abstract co-authors.
To browse abstracts that were selected for presentation
last year, please click
here.
The Society for Molecular Imaging
PO Box 293878
Kerrville, TX 78029-3878 USA
1-830-257-0112; Fax: 1-830-257-0119
Administrator
Charles Metzger
Email: cmetzger@molecularimaging.org
EUROPEAN OFFICE
Joan Oefner, CAE, Executive Director
Society for Molecular Imaging
BioPark II http://www.bioregio-regensburg.de
Josef-Engert-Str. 11
D-93053 Regensburg, Germany
Tel. +49 (0) 941-698-7645 FAX +49 (0) 941-698-7647
(do not dial the (0) if calling from outside Germany)
Email: joefner@molecularimaging.org
|